Skip to main content
Erschienen in: Clinical Research in Cardiology 2/2017

17.10.2016 | Original Paper

Coronary flow reserve in patients with resistant hypertension

verfasst von: Sebastian Völz, Sara Svedlund, Bert Andersson, Gan Li-Ming, Bengt Rundqvist

Erschienen in: Clinical Research in Cardiology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Resistant hypertension is associated with increased risk for cardiovascular events. Coronary flow reserve (CFR) is impaired in patients with hypertension and an independent predictor of cardiac mortality. However, there are no published data on CFR in the subset of treatment-resistant hypertension. The aim of this study was to assess CFR in patients with resistant hypertension. Twenty-five consecutive patients with primary resistant hypertension, scheduled for renal denervation, 25 matched patients with controlled hypertension, and 25 healthy controls underwent transthoracic colour Doppler echocardiography at rest and during adenosine infusion. Patients with hypertension were pair-matched with regard to age, sex, ischemic heart disease, diabetes mellitus, smoking status, and body-mass index. Healthy controls were selected according to age and sex. Mean flow velocity was measured in the left coronary anterior descending artery. Baseline mean flow velocities were similar in patients with controlled and resistant hypertension. CFR was significantly lower in patients with resistant hypertension as compared to individuals with non-resistant hypertension (2.7 ± 0.6 vs. 3.1 ± 0.8; p = 0.03). Systolic office blood pressure was significantly higher in patients with resistant hypertension (169 ± 20 vs. 144 ± 21 mm Hg; p < 0.01). Heart rate, ventricular mass, and ejection fraction were similar in the two groups. Healthy controls showed significantly lower baseline velocity, higher CFR, and lower blood pressure as compared to hypertensives. Resistant hypertension was associated with impaired CFR as compared to individuals with non-resistant hypertension indicating impaired cardiac microvascular function which may contribute to the increased risk of adverse outcome in patients with resistant hypertension.
Literatur
1.
Zurück zum Zitat Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V et al (2001) High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 19(11):2063–2070CrossRefPubMed Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V et al (2001) High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 19(11):2063–2070CrossRefPubMed
3.
Zurück zum Zitat Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL et al (2012) Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 125(13):1635–1642CrossRefPubMedPubMedCentral Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL et al (2012) Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 125(13):1635–1642CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Hozumi T, Yoshida K, Akasaka T, Asami Y, Ogata Y, Takagi T et al (1998) Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 32(5):1251–1259CrossRefPubMed Hozumi T, Yoshida K, Akasaka T, Asami Y, Ogata Y, Takagi T et al (1998) Noninvasive assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery by Doppler echocardiography: comparison with invasive technique. J Am Coll Cardiol 32(5):1251–1259CrossRefPubMed
5.
Zurück zum Zitat Lethen H, Tries HP, Kersting S, Lambertz H (2003) Validation of noninvasive assessment of coronary flow velocity reserve in the right coronary artery. A comparison of transthoracic echocardiographic results with intracoronary Doppler flow wire measurements. Eur Heart J 24(17):1567–1575CrossRefPubMed Lethen H, Tries HP, Kersting S, Lambertz H (2003) Validation of noninvasive assessment of coronary flow velocity reserve in the right coronary artery. A comparison of transthoracic echocardiographic results with intracoronary Doppler flow wire measurements. Eur Heart J 24(17):1567–1575CrossRefPubMed
6.
Zurück zum Zitat Cortigiani L, Rigo F, Gherardi S, Bovenzi F, Molinaro S, Picano E et al (2012) Coronary flow reserve during dipyridamole stress echocardiography predicts mortality. JACC Cardiovasc Imaging 5(11):1079–1085CrossRefPubMed Cortigiani L, Rigo F, Gherardi S, Bovenzi F, Molinaro S, Picano E et al (2012) Coronary flow reserve during dipyridamole stress echocardiography predicts mortality. JACC Cardiovasc Imaging 5(11):1079–1085CrossRefPubMed
7.
Zurück zum Zitat Sicari R, Rigo F, Cortigiani L, Gherardi S, Galderisi M, Picano E (2009) Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries. Am J Cardiol 103(5):626–631CrossRefPubMed Sicari R, Rigo F, Cortigiani L, Gherardi S, Galderisi M, Picano E (2009) Additive prognostic value of coronary flow reserve in patients with chest pain syndrome and normal or near-normal coronary arteries. Am J Cardiol 103(5):626–631CrossRefPubMed
8.
Zurück zum Zitat Cortigiani L, Rigo F, Gherardi S, Sicari R, Galderisi M, Bovenzi F et al (2007) Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 50(14):1354–1361CrossRefPubMed Cortigiani L, Rigo F, Gherardi S, Sicari R, Galderisi M, Bovenzi F et al (2007) Additional prognostic value of coronary flow reserve in diabetic and nondiabetic patients with negative dipyridamole stress echocardiography by wall motion criteria. J Am Coll Cardiol 50(14):1354–1361CrossRefPubMed
9.
Zurück zum Zitat Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan M, Gullu H et al (2007) Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 115(5):593–599CrossRefPubMed Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan M, Gullu H et al (2007) Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 115(5):593–599CrossRefPubMed
10.
Zurück zum Zitat Tsiachris D, Tsioufis C, Dimitriadis K, Syrseloudis D, Rousos D, Kasiakogias A et al (2012) Relation of impaired coronary microcirculation to increased urine albumin excretion in patients with systemic hypertension and no epicardial coronary arterial narrowing. Am J Cardiol 109(7):1026–1030CrossRefPubMed Tsiachris D, Tsioufis C, Dimitriadis K, Syrseloudis D, Rousos D, Kasiakogias A et al (2012) Relation of impaired coronary microcirculation to increased urine albumin excretion in patients with systemic hypertension and no epicardial coronary arterial narrowing. Am J Cardiol 109(7):1026–1030CrossRefPubMed
11.
Zurück zum Zitat Wittfeldt A, Emanuelsson H, Brandrup-Wognsen G, van Giezen JJJ, Jonasson J, Nylander S et al (2013) Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans. J Am Coll Cardiol 61(7):723–727CrossRefPubMed Wittfeldt A, Emanuelsson H, Brandrup-Wognsen G, van Giezen JJJ, Jonasson J, Nylander S et al (2013) Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans. J Am Coll Cardiol 61(7):723–727CrossRefPubMed
12.
Zurück zum Zitat Armstrong AC, Gidding S, Gjesdal O, Wu C, Bluemke DA, Lima JA (2012) LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. JACC Cardiovasc Imaging 5(8):837–848CrossRefPubMedPubMedCentral Armstrong AC, Gidding S, Gjesdal O, Wu C, Bluemke DA, Lima JA (2012) LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. JACC Cardiovasc Imaging 5(8):837–848CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J (1991) Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 11(6):565–577CrossRefPubMed Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J (1991) Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol 11(6):565–577CrossRefPubMed
14.
Zurück zum Zitat National Clinical Guideline C (2011) National Institute for Health and Clinical Excellence: Guidance. Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. London, Royal College of Physicians (UK) National Clinical Guideline Centre National Clinical Guideline C (2011) National Institute for Health and Clinical Excellence: Guidance. Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. London, Royal College of Physicians (UK) National Clinical Guideline Centre
15.
Zurück zum Zitat Persell SD (2011) Prevalence of resistant hypertension in the United States, 2003–2008. Hypertension 57(6):1076–1080CrossRefPubMed Persell SD (2011) Prevalence of resistant hypertension in the United States, 2003–2008. Hypertension 57(6):1076–1080CrossRefPubMed
16.
Zurück zum Zitat Baumgart D, Haude M, Liu F, Ge J, Goerge G, Erbel R (1998) Current concepts of coronary flow reserve for clinical decision making during cardiac catheterization. Am Heart J 136(1):136–149CrossRefPubMed Baumgart D, Haude M, Liu F, Ge J, Goerge G, Erbel R (1998) Current concepts of coronary flow reserve for clinical decision making during cardiac catheterization. Am Heart J 136(1):136–149CrossRefPubMed
17.
Zurück zum Zitat Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23(2):168–175CrossRefPubMed Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23(2):168–175CrossRefPubMed
18.
19.
Zurück zum Zitat Brush JE Jr, Faxon DP, Salmon S, Jacobs AK, Ryan TJ (1992) Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 19(4):809–815CrossRefPubMed Brush JE Jr, Faxon DP, Salmon S, Jacobs AK, Ryan TJ (1992) Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol 19(4):809–815CrossRefPubMed
20.
Zurück zum Zitat Ghiadoni L, Taddei S, Virdis A, Sudano I, Di Legge V, Meola M et al (1998) Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension 32(1):25–32CrossRefPubMed Ghiadoni L, Taddei S, Virdis A, Sudano I, Di Legge V, Meola M et al (1998) Endothelial function and common carotid artery wall thickening in patients with essential hypertension. Hypertension 32(1):25–32CrossRefPubMed
21.
Zurück zum Zitat Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE (1994) Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24(6):1468–1474CrossRefPubMed Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE (1994) Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24(6):1468–1474CrossRefPubMed
22.
Zurück zum Zitat Egashira K, Suzuki S, Hirooka Y, Kai H, Sugimachi M, Imaizumi T et al (1995) Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 25(2):201–206CrossRefPubMed Egashira K, Suzuki S, Hirooka Y, Kai H, Sugimachi M, Imaizumi T et al (1995) Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 25(2):201–206CrossRefPubMed
23.
Zurück zum Zitat Rubanyi GM, Romero JC, Vanhoutte PM (1986) Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250(6 Pt 2):H1145–H1149PubMed Rubanyi GM, Romero JC, Vanhoutte PM (1986) Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 250(6 Pt 2):H1145–H1149PubMed
24.
Zurück zum Zitat Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T et al (1989) Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 161(2):859–864CrossRefPubMed Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T et al (1989) Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 161(2):859–864CrossRefPubMed
25.
Zurück zum Zitat Brush JE Jr, Cannon RO 3rd, Schenke WH, Bonow RO, Leon MB, Maron BJ et al (1988) Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 319(20):1302–1307CrossRefPubMed Brush JE Jr, Cannon RO 3rd, Schenke WH, Bonow RO, Leon MB, Maron BJ et al (1988) Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 319(20):1302–1307CrossRefPubMed
26.
Zurück zum Zitat Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes DR Jr, Lerman A (2000) Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 35(6):1654–1660CrossRefPubMed Hamasaki S, Al Suwaidi J, Higano ST, Miyauchi K, Holmes DR Jr, Lerman A (2000) Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 35(6):1654–1660CrossRefPubMed
27.
Zurück zum Zitat Grassi G, Seravalle G, Brambilla G, Pini C, Alimento M, Facchetti R et al (2014) Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension. Int J Cardiol 177(3):1020–1025CrossRefPubMed Grassi G, Seravalle G, Brambilla G, Pini C, Alimento M, Facchetti R et al (2014) Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension. Int J Cardiol 177(3):1020–1025CrossRefPubMed
28.
Zurück zum Zitat Mancia G, Grassi G (2014) The autonomic nervous system and hypertension. Circ Res 114(11):1804–1814CrossRefPubMed Mancia G, Grassi G (2014) The autonomic nervous system and hypertension. Circ Res 114(11):1804–1814CrossRefPubMed
29.
Zurück zum Zitat Dahlof B, Pennert K, Hansson L (1992) Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 5(2):95–110PubMed Dahlof B, Pennert K, Hansson L (1992) Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 5(2):95–110PubMed
30.
Zurück zum Zitat Fagard R, Staessen JA, Thijs L (1995) The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. J Hypertens 13(8):823–829CrossRefPubMed Fagard R, Staessen JA, Thijs L (1995) The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. J Hypertens 13(8):823–829CrossRefPubMed
31.
Zurück zum Zitat Missault LH, De Buyzere ML, De Bacquer DD, Duprez DD, Clement DL (2002) Relationship between left ventricular mass and blood pressure in treated hypertension. J Hum Hypertens 16(1):61–66CrossRefPubMed Missault LH, De Buyzere ML, De Bacquer DD, Duprez DD, Clement DL (2002) Relationship between left ventricular mass and blood pressure in treated hypertension. J Hum Hypertens 16(1):61–66CrossRefPubMed
32.
Zurück zum Zitat Heesen WF, Beltman FW, May JF, Smit AJ, de Graeff PA, Havinga TK et al (1997) High prevalence of concentric remodeling in elderly individuals with isolated systolic hypertension from a population survey. Hypertension 29(2):539–543CrossRefPubMed Heesen WF, Beltman FW, May JF, Smit AJ, de Graeff PA, Havinga TK et al (1997) High prevalence of concentric remodeling in elderly individuals with isolated systolic hypertension from a population survey. Hypertension 29(2):539–543CrossRefPubMed
33.
Zurück zum Zitat Cuspidi C, Rescaldani M, Sala C, Grassi G (2014) Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens 32(1):16–25CrossRefPubMed Cuspidi C, Rescaldani M, Sala C, Grassi G (2014) Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens 32(1):16–25CrossRefPubMed
34.
Zurück zum Zitat Himeno E, Nishino K, Nakashima Y, Kuroiwa A, Ikeda M (1996) Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects. Am Heart J 131(2):313–319CrossRefPubMed Himeno E, Nishino K, Nakashima Y, Kuroiwa A, Ikeda M (1996) Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects. Am Heart J 131(2):313–319CrossRefPubMed
35.
Zurück zum Zitat Truong QA, Toepker M, Mahabadi AA, Bamberg F, Rogers IS, Blankstein R et al (2009) Relation of left ventricular mass and concentric remodeling to extent of coronary artery disease by computed tomography in patients without left ventricular hypertrophy: ROMICAT study. J Hypertens 27(12):2472–2482CrossRefPubMedPubMedCentral Truong QA, Toepker M, Mahabadi AA, Bamberg F, Rogers IS, Blankstein R et al (2009) Relation of left ventricular mass and concentric remodeling to extent of coronary artery disease by computed tomography in patients without left ventricular hypertrophy: ROMICAT study. J Hypertens 27(12):2472–2482CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Eguchi K, Boden-Albala B, Jin Z, Rundek T, Sacco RL, Homma S et al (2008) Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population. Am J Cardiol 101(12):1787–1791CrossRefPubMedPubMedCentral Eguchi K, Boden-Albala B, Jin Z, Rundek T, Sacco RL, Homma S et al (2008) Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population. Am J Cardiol 101(12):1787–1791CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi F, Feruglio GA et al (1992) Prevalence and determinants of carotid atherosclerosis in a general population. Stroke J Cereb Circ 23(12):1705–1711CrossRef Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi F, Feruglio GA et al (1992) Prevalence and determinants of carotid atherosclerosis in a general population. Stroke J Cereb Circ 23(12):1705–1711CrossRef
38.
Zurück zum Zitat Ferrieres J, Elias A, Ruidavets JB, Cantet C, Bongard V, Fauvel J et al (1999) Carotid intima-media thickness and coronary heart disease risk factors in a low-risk population. J Hypertens 17(6):743–748CrossRefPubMed Ferrieres J, Elias A, Ruidavets JB, Cantet C, Bongard V, Fauvel J et al (1999) Carotid intima-media thickness and coronary heart disease risk factors in a low-risk population. J Hypertens 17(6):743–748CrossRefPubMed
39.
Zurück zum Zitat Mannami T, Konishi M, Baba S, Nishi N, Terao A (1997) Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke; J Cereb Circ 28(3):518–525CrossRef Mannami T, Konishi M, Baba S, Nishi N, Terao A (1997) Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke; J Cereb Circ 28(3):518–525CrossRef
40.
Zurück zum Zitat Takiuchi S, Rakugi H, Fujii H, Kamide K, Horio T, Nakatani S et al (2003) Carotid intima-media thickness is correlated with impairment of coronary flow reserve in hypertensive patients without coronary artery disease. Hypertens Res 26(12):945–951CrossRefPubMed Takiuchi S, Rakugi H, Fujii H, Kamide K, Horio T, Nakatani S et al (2003) Carotid intima-media thickness is correlated with impairment of coronary flow reserve in hypertensive patients without coronary artery disease. Hypertens Res 26(12):945–951CrossRefPubMed
41.
Zurück zum Zitat Gullu H, Erdogan D, Caliskan M, Tok D, Yildirim E, Ulus T et al (2006) Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter. Echocardiography (Mount Kisco, NY) 23(10):835–842CrossRef Gullu H, Erdogan D, Caliskan M, Tok D, Yildirim E, Ulus T et al (2006) Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter. Echocardiography (Mount Kisco, NY) 23(10):835–842CrossRef
42.
Zurück zum Zitat Galderisi M, Cicala S, Caso P, De Simone L, D’Errico A, Petrocelli A et al (2002) Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 90(8):860–864CrossRefPubMed Galderisi M, Cicala S, Caso P, De Simone L, D’Errico A, Petrocelli A et al (2002) Coronary flow reserve and myocardial diastolic dysfunction in arterial hypertension. Am J Cardiol 90(8):860–864CrossRefPubMed
43.
Zurück zum Zitat Barra S, Vitagliano A, Cuomo V, Vitagliano G, Gaeta G (2009) Vascular and metabolic effects of angiotensin II receptor blockers. Expert Opin Pharmacother 10(2):173–189CrossRefPubMed Barra S, Vitagliano A, Cuomo V, Vitagliano G, Gaeta G (2009) Vascular and metabolic effects of angiotensin II receptor blockers. Expert Opin Pharmacother 10(2):173–189CrossRefPubMed
44.
Zurück zum Zitat Lethen H, Tries HP, Kersting S, Bramlage P, Lambertz H (2011) Improvement of coronary microvascular function after Angiotensin receptor blocker treatment with irbesartan in patients with systemic hypertension. J Clin Hypertens (Greenwich, Conn) 13(3):155–161CrossRef Lethen H, Tries HP, Kersting S, Bramlage P, Lambertz H (2011) Improvement of coronary microvascular function after Angiotensin receptor blocker treatment with irbesartan in patients with systemic hypertension. J Clin Hypertens (Greenwich, Conn) 13(3):155–161CrossRef
45.
Zurück zum Zitat Tomas JP, Moya JL, Barrios V, Campuzano R, Guzman G, Megias A et al (2006) Effect of candesartan on coronary flow reserve in patients with systemic hypertension. J Hypertens 24(10):2109–2114CrossRefPubMed Tomas JP, Moya JL, Barrios V, Campuzano R, Guzman G, Megias A et al (2006) Effect of candesartan on coronary flow reserve in patients with systemic hypertension. J Hypertens 24(10):2109–2114CrossRefPubMed
Metadaten
Titel
Coronary flow reserve in patients with resistant hypertension
verfasst von
Sebastian Völz
Sara Svedlund
Bert Andersson
Gan Li-Ming
Bengt Rundqvist
Publikationsdatum
17.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 2/2017
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-016-1043-4

Weitere Artikel der Ausgabe 2/2017

Clinical Research in Cardiology 2/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.